Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis

Infection and Immunity

Volumn 64, Issue 4, 1996, Pages 1379-1384

  Yeaman, Michael R ^a,b   Soldan, Samantha S ^a   Ghannoum, M A ^a,b   Edwards Jr , John E ^a,b   Filler, Scott G ^a,b   Bayer, Arnold S ^a,b  

^a St John's Cardiovascular Research Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN; RESTRICTION ENDONUCLEASE; THROMBIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CELL ADHESION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCARDITIS; GENOTYPE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABBIT; THROMBOCYTE; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

EID: 0029964527     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.4.1379-1384.1996     Document Type: Article

References (43)

1. Bancsi, M. J. L. M. F., J. Thompson, and R. M. Bertina. 1994. Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis Infect. Immun. 62:5669-5672.
2. Branchini, M. L., M. A. Pfaller, J. Rhine-Chalberg, T. Frempong, and H. D. Isenberg. 1994. Genotypic variation and slime production among blood isolates and catheter isolates of Candida parapsilosis. J. Clin Microbiol. 32: 452-456.
3. Calderone, R. A., R. L. Cihlar, D. D. S. Lee, K. Hoberg, and W. M. Scheld. 1985 Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans. J Infect. Dis. 152:710-715.
4. Calderone, R. A., M. F. Rotondo, and M. A. Sande. 1978. Candida albicans endocarditis - ultrastructural studies of vegetation formation. Infect. Immun 20:279-289.
5. Dankert, J., J. van Der Werff, S. A. J. Zaat, W. Joldersma, D. Klein, and J. Hess. 1995. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis Infect. Immun. 63:663-671.
6. Drake, T. A., and M. Pang. 1988. Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J. Infect. Dis. 157: 749-756.
7. Drake, T. A., and M. Pang. 1989 Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells. Infect. Immun. 57:507-512.
8. Drake, T. A., G. M. Rodgers, and M. A. Sande. 1984. Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J. Clin. Invest. 73:1750-1753.
9. Durack, D. T., and P. B. Beeson. 1972. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp. Pathol. 53:44-49
10. Edwards, J. E., Jr. 1991. Invasive candida infections: evolution of a fungal pathogen. N. Engl. J. Med. 324:1060-1062.
11. Edwards, J. E., Jr. 1995. Candida species, p. 2289-2306. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed ). Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York.
12. Filler, S. G., J. N. Swerdloff, C. Hobbs, and P. M. Luckett. 1995. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 63: 976-983.
13. Horn, R., B. Wong, T. E. Kiehn, and D. Armstrong. 1985. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev. Infect. Dis. 7:646-655.
14. Kaminishi, H., H. Miyaguchi, T. Tamaki, N. Suenaga, M. Hisamatsu, I. Mihashi, H. Matsumoto, H. Maeda, and Y. Hagihara. 1995. Degradation of humoral host defense by Candida albicans proteinase. Infect Immun. 63: 984-988.
15. Klotz, S. A. 1992. Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin. Infect. Dis. 14: 340-347.
16. Klotz, S. A., J. L. Harrison, and R. P. Misra. 1989. Aggregated platelets enhance adherence of Candida yeasts to endothelium. J. Infect. Dis. 160: 669-677.
17. Klotz, S. A., R. L. Smith, and B. W. Stewart. 1992. Effect of an arginine-glycine-aspartic acid (RGD)-contaimng peptide on hematogenous candidal infections in rabbits. Antimicrob. Agents. Chemother. 36:132-136.
18. Liss, R. H., and R. J. Letourneau. 1989 Fungispecificity of fluconazole against Candida albicans. Mycopathologia 108:173-178.
19. Lopez-Ribot, J. L., J. P. Martinez, and W. L. Chaffin. 1995. Comparative study of the C3d receptor and 58-kilodalton fibrinogen-binding mannoproteins of Candida albicans. Infect. Immun. 63:2126-2132.
20. Maisch, P. A., and R. A. Calderone. 1980. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect. Immun. 27:650-656.
21. Maisch, P. A., and R. A. Calderone. 1981 Role of surface mannans in the adherence of Candida albicans to fibrin-platelet clots formed in vitro. Infect. Immun 32:92-97.
22. Moyer, D. V., and J. E. Edwards, Jr. 1992. Fungal endocarditis, p. 299-312. In D. Kaye (ed ). Infective endocarditis, 2nd ed. Raven Press, New York.
23. Norenberg, R. G., G. K. Sethi, S. M. Scott, and T. Takaro. 1975. Opportunistic endocarditis following open-heart surgery Thorac. Surg. 19:592-604.
24. Robert, R., J. M. Senet, C. Mahaze, V. Annaix, M. Miegeville, J. P. Bou chara, G. Tronchin, and A. Marot-Leblond. 1992 Molecular basis of the interactions between Candida albicans, fibrinogen, and platelets. J. Mycol Med 2:19-23.
25. Rotrosen, D., J. E. Edwards, Jr., T. R. Gibson, J. C. Moore, A. H. Cohen, and I. Green. 1985. Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J. Infect Dis. 152:1264-1274.
26. Rubinstein, E., E. R. Noriega, M. A. Simberkoff, R. Holzman, and J. J. Rahal. 1975. Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) 54:331-344.
27. Schaberg, D. R., D. H. Culver, and R. P. Gaines. 1991 Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B): 72-75.
28. Scheld, W. M., and M. A. Sande. 1995. Endocarditis and intravascular infections, p. 740-782. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone. New York.
29. Scheld, W. M., J. A. Valone, and M. A. Sande. 1978. Bacterial adherence in the pathogenesis of streptococcal endocarditis - bacterial dextran, platelets, and fibrin. J. Clin. Invest. 61:1394-1404.
30. Scheld, W. M., O. Zak, K. Vosbeck, and M. A. Sande. 1981. Bacterial adhesion in the pathogenesis of infective endocarditis. J. Clin. Invest. 68: 1381-1384.
31. Seelig, M. S., P. J. Kozinn, P. Goldberg, and A. R. Berger. 1979. Fungal endocarditis: patients at risk and their treatment. Postgrad Med. J. 55: 632-641.
32. Seelig, M. S., C. P. Speth, P. J. Kozinn, C. L. Taschdjian, E. F. Toni, and P. Goldberg. 1974. Patterns of Candida endocarditis following cardiac surgery importance of early diagnosis and therapy analysis of 91 cases Prog. Cardiovasc. Dis. 18:125-160
33. Skerl, K. G., R. A. Calderone, and T. Sreevalsan. 1981. Platelet interactions with Candida albicans. Infect. Immun. 34:938-943.
34. Sullam, P. M., U. Frank, M. R. Yeaman, M. G. Täuber, A. S. Bayer, and H. F. Chambers. 1993 Effect of thrombocytopenia on the early course of streptococcal endocarditis. J. Infect. Dis. 168:910-914.
35. Voss, A. R. J. Hollis, M. A. Pfaller, R. P. Wenzel, and B. N. Doebbeling. 1994. Investigation of the sequence of colonization and candidemia in non-neutropenic patients. J. Clin. Microbiol. 32:975-980.
36. Walsh, T. J., and P. A. Pizzo. 1988. Treatment of systemic fungal infections: recent progress and current problems Eur J. Clin Microbiol. Infect. Dis. 7: 460-475.
37. Witt, M. D., and A. S. Bayer. 1991. Comparison of fluconazole and amphothericin B for prevention and treatment of experimental Candida endocarditis. Antimicrob Agents Chemother. 35:2481-2485
38. Wu, T., M. R. Yeaman, and A. S. Bayer. 1994. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob. Agents Chemother. 38:729-732.
39. Yeaman, M. R., A. S. Ibrahim, J. E. Edwards, Jr., A. S. Bayer, and M. A. Ghannoum. 1993 Thrombin-induced platelet microbicidal protein is fungicidal in vitro Antimicrob Agents Chemother. 37:546-553.
40. Yeaman, M. R., A. S. Ibrahim, J. A. Ritchie, S. G. Filler, A. S. Bayer, J. E. Edwards, Jr., and M. A. Ghannoum. 1995. Sublethal concentrations of platelet microbicidal protein reduce Candida albicans interactions with vascular endothelial cells in vitro, abstr. no. B-42. In 1995 IDSA Annual Meeting. San Francisco, Calif. Infectious Diseases Society of America, Washington, D C.
41. Yeaman, M. R., D. C. Norman, and A. S. Bayer. 1992. Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro. Infect. Immun 60: 2368-2374.
42. Yeaman, M. R., S. M. Puentes, D. C. Norman, and A. S. Bayer. 1992. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect. Immun. 60:1202-1209
43. Yeaman, M. R., P. M. Sullam, P. F. Dazin, M. A. Ghannoum, J. E. Edwards, Jr., and A. S. Bayer. 1994. Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro. Antimicrob. Agents Chemother. 38:1460-1465.